These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34269079)

  • 41. Bioprinting stem cells: building physiological tissues one cell at a time.
    Scognamiglio C; Soloperto A; Ruocco G; Cidonio G
    Am J Physiol Cell Physiol; 2020 Sep; 319(3):C465-C480. PubMed ID: 32639873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
    Skardal A; Shupe T; Atala A
    Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioprinting towards Physiologically Relevant Tissue Models for Pharmaceutics.
    Peng W; Unutmaz D; Ozbolat IT
    Trends Biotechnol; 2016 Sep; 34(9):722-732. PubMed ID: 27296078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 45. High throughput direct 3D bioprinting in multiwell plates.
    Hwang HH; You S; Ma X; Kwe L; Victorine G; Lawrence N; Wan X; Shen H; Zhu W; Chen S
    Biofabrication; 2021 Mar; 13(2):. PubMed ID: 32299077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models.
    Parrish J; Lim KS; Baer K; Hooper GJ; Woodfield TBF
    Lab Chip; 2018 Sep; 18(18):2757-2775. PubMed ID: 30117514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Method Development and Application of an Accelerated Solution Stability Screen for Drug Discovery.
    Gomez-Sanchez R; Besley S; Zeliku Z; Young RJ
    SLAS Discov; 2020 Dec; 25(10):1191-1196. PubMed ID: 32522054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can preclinical drug development help to predict adverse events in clinical trials?
    Chi LH; Burrows AD; Anderson RL
    Drug Discov Today; 2022 Jan; 27(1):257-268. PubMed ID: 34469805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease.
    Rodboon T; Yodmuang S; Chaisuparat R; Ferreira JN
    SLAS Discov; 2022 Apr; 27(3):151-158. PubMed ID: 35058190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic screening techniques for
    Love MS; McNamara CW
    Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
    [No Abstract]   [Full Text] [Related]  

  • 51. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
    Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organs-on-chips at the frontiers of drug discovery.
    Esch EW; Bahinski A; Huh D
    Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microfluidics-assisted in vitro drug screening and carrier production.
    Tsui JH; Lee W; Pun SH; Kim J; Kim DH
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1575-88. PubMed ID: 23856409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
    Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
    SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug discovery through stem cell-based organoid models.
    Ranga A; Gjorevski N; Lutolf MP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():19-28. PubMed ID: 24582599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Next-Generation Compound Delivery Platforms to Support Miniaturized Biology.
    Bhatt S; Crimmin S; Gross J; Nixon E; Truong M; Weglos M; Kallal L
    SLAS Technol; 2019 Jun; 24(3):245-255. PubMed ID: 30726680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microfabrication of liver and heart tissues for drug development.
    Brown GE; Khetani SR
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
    Martin J
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.13. PubMed ID: 22294376
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Romussi S; Giunti S; Andersen N; De Rosa MJ
    Expert Opin Drug Discov; 2024 May; 19(5):565-585. PubMed ID: 38509691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.